Results for "Exosome Therapy"

20 articles

Blood Test Using Exosomes Shows Promise for Monitoring Rare Sarcoma Cancers
Cancer Research

Blood Test Using Exosomes Shows Promise for Monitoring Rare Sarcoma Cancers

French study explores how tiny cellular packages in blood could predict cancer recurrence and guide treatment decisions.

Clinical Trial
Mar 28, 2026 2
Melanoma Drug Resistance Linked to Cellular Communication Vesicles Called Exosomes
Cancer Research

Melanoma Drug Resistance Linked to Cellular Communication Vesicles Called Exosomes

French researchers studied how tiny cellular packages called exosomes may help melanoma cells resist treatment and spread throughout the body.

Clinical Trial
Mar 28, 2026 0
Blood Test Detects Hidden Cancer Cells After Colorectal Surgery Using Exosomes
Cancer Research

Blood Test Detects Hidden Cancer Cells After Colorectal Surgery Using Exosomes

New liquid biopsy technique identifies molecular residual disease in colorectal cancer patients to guide personalized treatment decisions.

Clinical Trial
Mar 28, 2026 1
New CSF Test Could Revolutionize Brain Cancer Detection Using Exosome Analysis
Cancer Research

New CSF Test Could Revolutionize Brain Cancer Detection Using Exosome Analysis

Small study explores cerebrospinal fluid exosomes to better diagnose breast cancer spread to brain and spinal cord.

Clinical Trial
Mar 29, 2026 0
Microfluidic Chip Detects Lung Metastasis in Osteosarcoma Using Blood Exosomes
Cancer Research

Microfluidic Chip Detects Lung Metastasis in Osteosarcoma Using Blood Exosomes

New diagnostic chip analyzes blood exosomes to detect early lung spread of bone cancer, potentially improving treatment outcomes.

Clinical Trial
Mar 29, 2026 0
Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial
Cancer Research

Engineered Immune Cells Show Promise Against Advanced Cancer in Early Trial

Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.

Clinical Trial
Mar 28, 2026 0
New Blood Test Could Predict Stroke Recovery Success Using Tiny Cellular Messengers
Brain Health

New Blood Test Could Predict Stroke Recovery Success Using Tiny Cellular Messengers

Italian researchers developed a biosensor to track extracellular vesicles in blood, potentially personalizing stroke rehabilitation.

Clinical Trial
Mar 28, 2026 0
Placental Stem Cell Secretome Tested as GvHD Treatment in Phase 3 Trial
Autoimmune & Arthritis

Placental Stem Cell Secretome Tested as GvHD Treatment in Phase 3 Trial

A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.

Clinical Trial
May 12, 2026 0
Oncolytic Virus Therapy Shows Promise Against Advanced Metastatic Cancers
Cancer Research

Oncolytic Virus Therapy Shows Promise Against Advanced Metastatic Cancers

New viral therapy ASP9801 targets solid tumors directly, potentially offering hope for patients with advanced metastatic cancer.

Clinical Trial
Mar 28, 2026 0
New RNA Drug RBD7022 Enters Phase 1 Testing as Next-Gen LDL Cholesterol Lowerer
Heart Health

New RNA Drug RBD7022 Enters Phase 1 Testing as Next-Gen LDL Cholesterol Lowerer

A phase 1 trial tests RBD7022, a novel subcutaneous RNA-based therapy, for safety and dosing in adults with high LDL cholesterol.

Clinical Trial
May 27, 2026 0
Cancer Vaccine OSE2101 Tested Against Standard Chemotherapy in Advanced Lung Cancer
Cancer Research

Cancer Vaccine OSE2101 Tested Against Standard Chemotherapy in Advanced Lung Cancer

Phase 3 trial compared therapeutic vaccine OSE2101 to chemotherapy in 219 lung cancer patients after immunotherapy failure.

Clinical Trial
Mar 28, 2026 0
Triple Combination Cancer Immunotherapy Shows Promise in Advanced Solid Tumors
Cancer Research

Triple Combination Cancer Immunotherapy Shows Promise in Advanced Solid Tumors

Small trial tests novel three-drug approach combining immune checkpoint inhibitor, vaccine, and inflammation blocker for metastatic cancers.

Clinical Trial
Mar 29, 2026 1
EDP-305 Targets NASH in Phase 2 Trial Testing Two Doses Against Placebo
Metabolic Health

EDP-305 Targets NASH in Phase 2 Trial Testing Two Doses Against Placebo

Enanta Pharmaceuticals tests its FXR agonist EDP-305 in a completed Phase 2 randomized trial for non-alcoholic steatohepatitis.

Clinical Trial
Jun 18, 2026 0
Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment
Cancer Research

Natural Killer Cell Therapy Shows Promise for Advanced Cancer Treatment

Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.

Clinical Trial
Mar 29, 2026 0
Olpasiran Slashes Lp(a) Levels in Phase 2 Cardiovascular Trial
Heart Health

Olpasiran Slashes Lp(a) Levels in Phase 2 Cardiovascular Trial

Amgen's siRNA therapy olpasiran targets lipoprotein(a), a stubborn cardiovascular risk factor with no approved treatments.

Clinical Trial
Jun 14, 2026 0
RNA Drug Targets ANGPTL3 to Slash Triglycerides in Rare Fat Disorder
Metabolic Health

RNA Drug Targets ANGPTL3 to Slash Triglycerides in Rare Fat Disorder

A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.

Clinical Trial
Jun 23, 2026 0
Stem Cell Therapy Shows Promise for Reversing Lung Damage in COPD Patients
Regenerative Medicine

Stem Cell Therapy Shows Promise for Reversing Lung Damage in COPD Patients

Small trial tests autologous bronchial stem cells to repair damaged lung tissue in chronic obstructive pulmonary disease patients.

Clinical Trial
Mar 29, 2026 12
Liquid Biopsy Guides Targeted Lung Cancer Treatment in Breakthrough Trial
Cancer Research

Liquid Biopsy Guides Targeted Lung Cancer Treatment in Breakthrough Trial

New study shows how analyzing fluid from lungs can detect cancer mutations and guide personalized treatment decisions.

Clinical Trial
Mar 28, 2026 0
Repurposed Anti-Nausea Drug TEP Tested for Clearing Alzheimer's Brain Plaques
Brain Health

Repurposed Anti-Nausea Drug TEP Tested for Clearing Alzheimer's Brain Plaques

A Phase 2 trial investigates whether thiethylperazine, a decades-old antiemetic, can flush toxic amyloid beta from the brains of early AD patients.

Clinical Trial
Jun 12, 2026 0
CD226 Immune Receptor Explored as Predictor of Immunotherapy Response in Advanced Liver Cancer
Cancer Research

CD226 Immune Receptor Explored as Predictor of Immunotherapy Response in Advanced Liver Cancer

A French trial investigated whether circulating immune cell profiles, specifically CD226 expression, could predict who responds to Atezolizumab/Bevacizumab in advanced HCC.

Clinical Trial
Jun 9, 2026 0
Page 1 of 2Next